One injection per week, same active ingredient as the brand-name options, compounded and shipped directly to your door
Semaglutide GLP-1 is a revolutionary weight loss treatment that typically begins to show noticeable effects within 4 to 6 weeks of use
Individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN2) should discuss this with their clinician before considering any GLP-1based therapy, and should be alert to symptoms such as a neck lump, hoarseness, or difficulty swallowing
The binding of incretins to GPCRs triggers a cascade of intracellular events, including cyclic AMP production and the consequent activation of protein kinase A
Choosing your injection site Where you inject matters
Studies show that Wegovy (a higher-dose version of semaglutide) can help patients lose an average of 15% of their body weight over time